Operation of CoLaborator Kobe, an incubation space with fully-furnished lab and office infrastructure.

Consulting Service, Safety Management Service, Post-Marketing Pharmaceutical Service

Overview

Support resolving company’s problems with broad services.
1. Consulting Service
・Advise and interview support for responding inquiry matters to authorities
・Support obtaining and renewing the authorization of manufacturing and distribution
2. Safety Management Service
・Accept whole medicine and medical device’s safety management operation
3. Post-Marketing Pharmaceutical Service
・Construct package insert and related documents
・CMC pharmaceutical operation

DX and Open Innovation Support in the Medical and Healthcare Industry

Overview

To realize the vision of "creating more time for patients, families, doctors, and essential workers to engage with healthcare," we provide HX (Healthcare Experience) design and IT solutions to medical institutions and pharmaceutical companies to enhance the healthcare experience. Utilizing the open and global location of Kobe, along with medical networks in Tokyo, Osaka, and other bases, we leverage our expertise in digital marketing support, contract development, and insights gained from medical networks. Our value lies in "helping and saving people through HX design," and we are dedicated to solving HX (Healthcare Experience) and communication challenges.
From our experience in operating open innovation centers at national centers, we engage in various initiatives, including the establishment and support of startup companies, joint research support, and creating new opportunities for industry-academia-government collaboration. We will continue to propose innovative methods that can flexibly respond to the rapidly changing market and the diversifying needs and values of customers.

Strategic investment in venture companies engaged in research and development of pharmaceuticals and medical devices

Overview

We are actively investing in venture companies engaged in the research and development of pharmaceuticals and medical devices. We are committed to supporting the growth of venture companies and academia, which have limited funds, to enhance their value. In addition, the Gemseki Division of our parent company, Shin Nippon Biomedical Laboratories (SNBL), provides strong support for partnership-building and licensing activities that are essential for the promotion of these businesses. We and Gemseki Division will contribute to the advancement of medical care by providing a one-stop service for the creation of innovative drugs and medical devices as SNBL Group.

We help scientists devote themselves to their works, with simplifying research-involved tasks by develoring project-management system “reprua

Overview

We started with the mission of ‘’creating the world that enable scientists devoting themselves to their works’’.
We are developing the specialized project-managing system ‘’reprua’’ to optimize operating efficiencies of researching projects such as purchase and inventory management.

Operating Kobe Medical Device Development Center, Kobe Healthcare Industry Development center, etc.